IGC Pharma, Inc.IGCNYSE
Loading
Cash Flow PerformanceNormalizing
Percentile Rank43
Studio
Year-over-Year Change

Free cash flow yield

Latest
-24.20%
Near historical average
Percentile
P43
Within normal range
Streak
1 yr
Consecutive declineNormalizing
Average
-22.37%
Historical baseline
PeriodValueYoY Change
2025-24.20%-18.6%
2024-20.40%+52.5%
2023-42.95%-147.5%
2022-17.36%-5.2%
2021-16.50%+75.7%
2020-67.92%-1332.5%
2019-4.74%+65.2%
2018-13.63%-6.9%
2017-12.74%-288.0%
2016-3.28%-